Sugi Predict

Sugi Predict / Compounds / SCHEMBL1892811

SCHEMBL1892811

SCHEMBL1892811

CCOC(=O)n1nc2c(c1NC(=O)c1ccc(CN3CCCC3)cc1[N+](=O)[O-])CN(C(=O)OC(C)(C)C)CC2(C)C

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ PCSK9 Q8NBP7 1/20 0.33
▸ CTSB P07858 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ RORC P51449 2/20 0.31
▸ NR1H2 P55055 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2453090 0.86 MAPT (0.34) MAPTTP53THRBNPSR1LMNA
SCHEMBL1891834 0.86 ALDH1A1 (0.42) L3MBTL1TP53THRBNPSR1LMNA
SCHEMBL1887656 0.85 MAPT (0.39) L3MBTL1MAPTMAPK1LMNAALDH1A1
SCHEMBL1893808 0.85 MAPT (0.38) MAPTMAPK1NPSR1LMNAALDH1A1
SCHEMBL2678711 0.83 L3MBTL1 (0.36) L3MBTL1MAPTTP53THRBMAPK1
Hydrochloric Acid SCHEMBL2678708 0.83 L3MBTL1 (0.35) L3MBTL1MAPTTP53THRBMAPK1
SCHEMBL1887052 0.82 L3MBTL1 (0.34) L3MBTL1MAPTTP53THRBLMNA
SCHEMBL4291110 0.76 MAPT (0.40) MAPTLMNAALDH1A1
SCHEMBL4288974 0.75 KDM4E (0.41) MAPTMAPK1LMNAALDH1A1
SCHEMBL4278110 0.75 C5AR1 (0.35) L3MBTL1MAPTTP53THRBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 — — US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 — — US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 — — US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 — — US disclosed
EP-1968976-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-09-17 — — EP disclosed
WO-2007068619-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 L3MBTL1 3525/4885MAPT 2600/4885TP53 400/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 L3MBTL1 3525/4885MAPT 2600/4885TP53 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.